Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA issues warning over products containing altrenogest
BHA is carrying out further work to understand the implications of this issue in Europe. 

Trace levels of anabolic steroids found in some products 

The British Horseracing Authority (BHA) is making vets and trainers aware of an international issue regarding products that contain altrenogest.

Trace levels of the anabolic steroids trenbolone and/or trendione have been detected in products containing altrenogest, which is commonly referred to by its trade name, Regumate.

Racing Victoria (Australia) has advised trainers to immediately cease using such products and further investigations are now underway.

In the UK, one such product is licensed for use in horses - Regumate Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health).

After discussions with the European manufacturer, BHA said it can confirm that the product distributed in the UK is reportedly sourced from a separate location to the products that are currently under investigation.

However, in light of the international situation, BHA is strongly advising trainers to be cautious if using altrenogest in racing thoroughbreds.

The BHA published Detection Time for altrenogest is 288 hours (15 days). In contrast, a 24-hour withdrawal from racing is recommended in Australia for mares and fillies receiving oral altrenogest.

BHA is carrying out further work to understand the implications of this issue in Europe.  

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.